By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MaxCyte, Inc. 

22 Firstfield Road, Suite 250

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-944-1700 Fax: 301-944-1703


SEARCH JOBS


Industry
Biotechnology






Company News
MaxCyte, Inc. Release: Accelerating Product Development: From Transient Transfection To Stable Pools And Stable Clones 5/14/2014 9:15:57 AM
MaxCyte, Inc. Introduces Rapid, Automated, Scalable Flow Electroporation-Based Technology For Vaccine Development 3/20/2014 10:11:22 AM
MaxCyte, Inc. Introduces The 2014 Maxcyte STX Scalable Transfection System For Cell-Based Assay Applications At The SLAS 2014 Annual Conference & Exhibition 1/20/2014 10:53:03 AM
MaxCyte, Inc. Presents Data On Stable Cell Line Generation And Rapid, High Titer Production Of Antibodies And Proteins Using Flow Electroporation 12/9/2013 9:56:12 AM
MaxCyte, Inc. Presents Data On Stable Cell Line Generation And Rapid, High Titer Production Of Antibodies And Proteins Using Flow Electroporation 12/9/2013 9:37:13 AM
MaxCyte, Inc. Presents Scalable Flow Electroporation as a Universal Platform for High Titer Antibody and Protein Production at CHI’s PEGS Europe Summit 11/4/2013 8:06:37 AM
MaxCyte, Inc. Presents Large Scale Flow Electroporation for Process Development and Bioproduction at CHI’s 2013 BioProcessing Summit 8/19/2013 9:24:46 AM
Gram Scale Transient Antibody Production in CHO Cells With MaxCyte, Inc. Electroporation 6/18/2013 9:29:00 AM
MaxCyte, Inc. Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation 5/20/2013 10:55:23 AM
MaxCyte, Inc. Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation 5/20/2013 10:19:35 AM
12345678910...
//-->